Nursey Michael E. 4

What Happened
Michael E. Nursey, Senior Executive Vice President and Chief Domestic Banking Officer of Amerant Bancorp (AMTB), was awarded two equity-based grants on February 17, 2026: 5,939 restricted stock units (RSUs) and 5,939 performance-based restricted stock units (PSUs). Both awards are reported as derivative grants at $0.00 (no cash paid). In total the grants equal 11,878 units at target (RSUs + target PSUs), each unit representing the economic equivalent of one share of Class A common stock upon vesting.

Key Details

• Transaction date: February 17, 2026; Filing date: February 19, 2026 (filed within normal 2-business-day window).
• Reported price: $0.00 (award/grant, transaction code A).
• Award amounts: 5,939 RSUs + 5,939 PSUs (target) — 11,878 units reported in total.
• RSU vesting: vested in substantially equal installments on each of the first three anniversaries of the grant, subject to continued service.
• PSU vesting: performance-based over a 3-year period (Jan 1, 2026–Dec 31, 2028); actual payout can range from 40% to 180% of target based on Committee-set metrics (Relative Adjusted ROTA and Relative Total Shareholder Return). Reported number is the target number of PSUs.
• Shares owned after transaction: not stated in the supplied filing data.
• Remarks: Listed role — SEVP, Chief Domestic Banking Officer.

Context
These were compensation awards (derivative grants), not open-market purchases or sales. RSUs convert to shares upon vesting (time-based), while PSUs convert based on future performance and may pay out more or less than target. Such grants are common executive compensation and do not, by themselves, signal insider buying or selling intent.